These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8556996)

  • 1. Rocuronium bromide: time-course of action in underweight, normal weight, overweight and obese patients.
    Pühringer FK; Khuenl-Brady KS; Mitterschiffthaler G
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():107-10. PubMed ID: 8556996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should dosing of rocuronium in obese patients be based on ideal or corrected body weight?
    Meyhoff CS; Lund J; Jenstrup MT; Claudius C; Sørensen AM; Viby-Mogensen J; Rasmussen LS
    Anesth Analg; 2009 Sep; 109(3):787-92. PubMed ID: 19690247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of rocuronium bromide in obese female patients.
    Pühringer FK; Keller C; Kleinsasser A; Giesinger S; Benzer A
    Eur J Anaesthesiol; 1999 Aug; 16(8):507-10. PubMed ID: 10500937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients.
    Leykin Y; Pellis T; Lucca M; Lomangino G; Marzano B; Gullo A
    Anesth Analg; 2004 Oct; 99(4):1086-1089. PubMed ID: 15385355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In non-obese patients, duration of action of rocuronium is directly correlated with body mass index.
    Fujimoto M; Tanahira C; Nishi M; Yamamoto T
    Can J Anaesth; 2013 Jun; 60(6):552-6. PubMed ID: 23463483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rocuronium 0.3 mg x kg-1 (ED95) induces a normal peak effect but an altered time course of neuromuscular block in patients with Duchenne's muscular dystrophy.
    Muenster T; Schmidt J; Wick S; Forst J; Schmitt HJ
    Paediatr Anaesth; 2006 Aug; 16(8):840-5. PubMed ID: 16884467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of rocuronium bromide in adult patients.
    Alvarez-Gomez JA; Estelles ME; Fabregat J; Perez F; Brugger AJ
    Eur J Anaesthesiol Suppl; 1994; 9():53-6. PubMed ID: 7925209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of rocuronium bromide in patients with and without renal failure.
    Cooper RA; Mirakhur RK; Wierda JM; Maddineni VR
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():43-4. PubMed ID: 8557005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular recovery following rocuronium bromide single dose in infants.
    Rapp HJ; Altenmueller CA; Waschke C
    Paediatr Anaesth; 2004 Apr; 14(4):329-35. PubMed ID: 15078379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of a rocuronium-induced neuromuscular block in patients receiving prednisolone.
    Soltész S; Mencke T; Stunz M; Diefenbach C; Ziegeler S; Molter GP
    Acta Anaesthesiol Scand; 2009 Apr; 53(4):443-8. PubMed ID: 19317861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular pharmacodynamics of rocuronium in patients with major burns.
    Han T; Kim H; Bae J; Kim K; Martyn JA
    Anesth Analg; 2004 Aug; 99(2):386-92, table of contents. PubMed ID: 15271712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of hypothermia (surface cooling) on the time-course of action and on the pharmacokinetics of rocuronium in humans.
    Beaufort AM; Wierda JM; Belopavlovic M; Nederveen PJ; Kleef UW; Agoston S
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():95-106. PubMed ID: 8557016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An overview of the pharmacokinetics and pharmacodynamics of rocuronium bromide].
    Iwasaki H
    Masui; 2006 Jul; 55(7):826-33. PubMed ID: 16856542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-course of action and intubating conditions with rocuronium bromide under propofol-alfentanil anaesthesia.
    Hofmockel R; Benad G
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():69-72. PubMed ID: 8557010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of desflurane on rocuronium onset, clinical duration and maintenance requirements.
    Stout RG; Gan TJ; Glass PS; Silverman DG; Brull SJ
    Acta Anaesthesiol Belg; 2006; 57(4):349-53. PubMed ID: 17236635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early and late reversibility of rocuronium bromide.
    van den Broek L; Proost JH; Wierda JM
    Eur J Anaesthesiol Suppl; 1994; 9():128-32. PubMed ID: 7925203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of neuromuscular block of atracurium and rocuronium in adults.
    Hans P; Brichant JF; Franzen A; Faleres X; Lamy M
    Acta Anaesthesiol Belg; 1996; 47(2):53-8. PubMed ID: 8869671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of the dose-response and time course of recovery of atracurium and rocuronium.
    Xue F; Zhang Y; Liao X; Liu J; An G
    Chin Med J (Engl); 2000 Nov; 113(11):1019-21. PubMed ID: 11776116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical predictors of duration of action of cisatracurium and rocuronium administered long-term.
    Fassbender P; Geldner G; Blobner M; Hofmockel R; Rex C; Gautam S; Malhotra A; Eikermann M
    Am J Crit Care; 2009 Sep; 18(5):439-45. PubMed ID: 19723864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of the injection timing of ephedrine to reduce the onset time of rocuronium.
    Han DW; Chun DH; Kweon TD; Shin YS
    Anaesthesia; 2008 Aug; 63(8):856-60. PubMed ID: 18699898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.